134 related articles for article (PubMed ID: 8676511)
1. A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro.
Fernandez-Sesma A; Schulman JL; Moran TM
J Virol; 1996 Jul; 70(7):4800-4. PubMed ID: 8676511
[TBL] [Abstract][Full Text] [Related]
2. Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.
Pendzialek J; Roose K; Smet A; Schepens B; Kufer P; Raum T; Baeuerle PA; Muenz M; Saelens X; Fiers W
Antiviral Res; 2017 May; 141():155-164. PubMed ID: 28257797
[TBL] [Abstract][Full Text] [Related]
3. Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection.
De Vlieger D; Hoffmann K; Van Molle I; Nerinckx W; Van Hoecke L; Ballegeer M; Creytens S; Remaut H; Hengel H; Schepens B; Saelens X
Front Immunol; 2019; 10():2920. PubMed ID: 31921179
[TBL] [Abstract][Full Text] [Related]
4. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
[TBL] [Abstract][Full Text] [Related]
5. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice.
Treanor JJ; Tierney EL; Zebedee SL; Lamb RA; Murphy BR
J Virol; 1990 Mar; 64(3):1375-7. PubMed ID: 2304147
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin B-activated T cells can be redirected to inhibit multicycle virus replication.
Moran TM; Toy E; Kuzu Y; Kuzu H; Isobe H; Schulman JL
J Immunol; 1995 Jul; 155(2):759-65. PubMed ID: 7608553
[TBL] [Abstract][Full Text] [Related]
7. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of multicycle influenza virus replication by hybrid antibody-directed cytotoxic T lymphocyte lysis.
Moran TM; Usuba O; Kuzu H; Kuzu Y; Schulman J; Bona CA
J Immunol; 1991 Jan; 146(1):321-6. PubMed ID: 1824592
[TBL] [Abstract][Full Text] [Related]
9. Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells.
Melik-Nubarov NS; Suzdaltseva YuG ; Priss EL; Slepnev VI; Kabanov AV; Zhirnov OP; Sveshnikov PG; Severin ES
Biochem Mol Biol Int; 1993 Apr; 29(5):939-47. PubMed ID: 8508145
[TBL] [Abstract][Full Text] [Related]
10. Targeting of cytotoxic T cells against leukemic B cells by bispecific antibody (aCD3 x aCD19) does not distract the T cell from its primary target.
Klein SC; van der Burg SH; Boer LH; Melief CJ; Kast WM; de Gast GC; Bast EJ
J Immunol; 1997 Dec; 159(11):5545-9. PubMed ID: 9548495
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.
Wang Y; Zhou L; Shi H; Xu H; Yao H; Xi XG; Toyoda T; Wang X; Wang T
Biochem Biophys Res Commun; 2009 Jul; 385(1):118-22. PubMed ID: 19410554
[TBL] [Abstract][Full Text] [Related]
12. Recognition of the PB1, neuraminidase, and matrix proteins of influenza virus A/NT/60/68 by cytotoxic T lymphocytes.
Reay PA; Jones IM; Gotch FM; McMichael AJ; Brownlee GG
Virology; 1989 Jun; 170(2):477-85. PubMed ID: 2658303
[TBL] [Abstract][Full Text] [Related]
13. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.
Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC
Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
Wang R; Song A; Levin J; Dennis D; Zhang NJ; Yoshida H; Koriazova L; Madura L; Shapiro L; Matsumoto A; Yoshida H; Mikayama T; Kubo RT; Sarawar S; Cheroutre H; Kato S
Antiviral Res; 2008 Nov; 80(2):168-77. PubMed ID: 18598723
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity.
Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T
New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589
[TBL] [Abstract][Full Text] [Related]
16. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
Tamminen WL; Wraith D; Barber BH
Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
[TBL] [Abstract][Full Text] [Related]
17. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.
Price GE; Gaszewska-Mastarlarz A; Moskophidis D
J Virol; 2000 May; 74(9):3996-4003. PubMed ID: 10756011
[TBL] [Abstract][Full Text] [Related]
18. Targeting tumor cells with bispecific antibodies and T cells.
Kranz DM; Manning TC; Rund LA; Cho BK; Gruber MM; Roy EJ
J Control Release; 1998 Apr; 53(1-3):77-84. PubMed ID: 9741915
[TBL] [Abstract][Full Text] [Related]
19. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.
Jegerlehner A; Schmitz N; Storni T; Bachmann MF
J Immunol; 2004 May; 172(9):5598-605. PubMed ID: 15100303
[TBL] [Abstract][Full Text] [Related]
20. Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo.
Moreno MB; Titus JA; Cole MS; Tso JY; Le N; Paik CH; Bakács T; Zacharchuk CM; Segal DM; Wunderlich JR
Cancer Immunol Immunother; 1995 Mar; 40(3):182-90. PubMed ID: 7728777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
